Colo-rectal Cancer Clinical Trial
Official title:
Investigating the Role of SPG20,STK31 Genes in the Carcinogenesis of Colorectal Cancer
Colo rectal cancer is one of the greatest ,mutual malignancies worldwide ,accounting for an estimated 1.3 million new cases and >500,000 mortality ⁄ year . is the fourth leading cause of cancer-associated mortality worldwide with speedily ,cumulative ,occurrence rate in the worldwide
colo rectal cancer represents a global and local problem, as it is one of the commonest types
of cancer all over the world. Globally, Colo rectal cancer in women (9.2% of diagnoses) it is
the second most common cause of cancer . it is the third most common in men (10.0%). After
lung, stomach, and liver cancer it is the fourth most common cause of cancer death.
Cancer is a multistep procedure resulting from an ongoing accretion of genetic and epigenetic
fluctuations to the genome.
Spartin is a protein that in humans is encoded by the SPG20 gene. This protein may be
involved in endosomal trafficking, microtubule dynamics, or both functions. Aberrant promoter
methylation of genes is a common epigenetic alteration in colo rectal cancer .
This has stimulated the prospect to implement a dependable, reasonable and simple approach
for Colo rectal detection . The SPG20 gene is situated in chromosome band 13q13.3; the SPG20
gene converts the spartin protein, which is a multi functional protein that has formerly been
recognized to be complicated in intra cellular epidermal growth factor receptor trading , The
serine-threonine kinase 31 (STK31) gene was initially identified through cDNA subtraction as
a testis-specific protein kinase gene expressed in mouse spermatogonia . Recently, STK31 has
been described as a novel cancer testis (CT) antigen, highly expressed in Gastrointestinal
cancer cells (colo rectal, gastric and esophageal cancer), while restricted to testis and
fetal brain in normal tissues .
It was found that SPG20 is mutated in Troy er syndrome, an hereditary spastic paraplegia
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05074966 -
The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts
|
Phase 3 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Suspended |
NCT05124743 -
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
|
||
| Recruiting |
NCT05056389 -
Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)
|
Phase 1 | |
| Completed |
NCT04551001 -
Evaluation of Cold Forcep and Cold Snare Polypectomy for Polyps Less Than or Equal to 3mm in Size During Colonoscopy
|
N/A | |
| Completed |
NCT04551014 -
Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm
|
N/A | |
| Recruiting |
NCT04270500 -
The Impact of Physical Exercise on Sleep in Colorectal Cancer Patients During Prehabilitation Period
|
N/A | |
| Recruiting |
NCT03667911 -
Virtual Reality Videos in Improving Bowel Preparation Quality of Colonoscopy
|
N/A | |
| Not yet recruiting |
NCT04073680 -
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05572684 -
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Suspended |
NCT04108481 -
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03567850 -
Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC
|
N/A | |
| Recruiting |
NCT05870332 -
Nationwide Study of Artificial Intelligence in Adenoma Detection for Colonoscopy
|
||
| Completed |
NCT04534218 -
Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer
|
Phase 2 | |
| Enrolling by invitation |
NCT05590117 -
Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer
|
Early Phase 1 | |
| Recruiting |
NCT03129139 -
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT04195646 -
Computer Aided Detection of Polyps During Colonoscopy Procedures
|
N/A | |
| Not yet recruiting |
NCT03618329 -
Effect of Prehabilitation on the Lean Mass Index (IMM) in ERAS PROGRAMM.
|
N/A | |
| Terminated |
NCT03621982 -
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT03407417 -
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care
|
N/A |